IPC’s International Fellowship program offers early-career dermatologists and researchers interested in psoriasis the opportunity to learn directly from our global network of experts, demonstrating our commitment to developing the next generation of leaders in the field.
IPC offers two fellowship tracks: Clinical and Research. Both are 12-month programs that include virtual mentoring, skills development classes, and co-mentoring groups based on special interest topics. Clinical fellows will participate in up to four weeks of on-site clinical experience, while research fellows will spend up to twelve weeks on-site with a research mentor. Applicants may apply to one or both tracks through a single application.
The project is led by the Fellowship Program Advisory Committee.
Awarded fellows are matched with IPC Board Members or Councilors to observe and participate in clinical practice or research involving patients with psoriasis. Fellows gain hands-on experience in real-world settings, whether through investigating, diagnosing, and managing psoriasis in clinical practice, or participating in active research projects in the lab or clinic. In addition, the program fosters lasting professional relationships by engaging fellows in IPC activities and connecting them with global leaders in the field throughout the fellowship year.
The 2026 IPC International Fellowship Program is supported in part by: Johnson & Johnson
How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.
Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.
